Filing Details

Accession Number:
0000711377-13-000015
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-13 18:15:56
Reporting Period:
2013-05-09
Filing Date:
2013-05-13
Accepted Time:
2013-05-13 18:15:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1188979 C Jack Parnell Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-05-09 1,000 $16.71 11,073 No 4 M Direct
Common Stock Acquisiton 2013-05-09 2,000 $16.53 13,073 No 4 M Direct
Common Stock Acquisiton 2013-05-09 3,000 $20.33 16,073 No 4 M Direct
Common Stock Acquisiton 2013-05-09 1,333 $33.63 17,406 No 4 M Direct
Common Stock Acquisiton 2013-05-09 1,000 $34.13 18,406 No 4 M Direct
Common Stock Disposition 2013-05-09 3,619 $52.50 14,787 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock ( Right to Buy) Disposition 2013-05-09 1,000 $0.00 1,000 $16.71
Common Stock Common Stock (Right to Buy) Disposition 2013-05-09 2,000 $0.00 2,000 $16.53
Common Stock Common Stock (Right to Buy) Disposition 2013-05-09 3,000 $0.00 3,000 $20.33
Common Stock Common Stock (Right to Buy) Disposition 2013-05-09 1,333 $0.00 1,333 $33.63
Common Stock Common Stock (Right to Buy) Disposition 2013-05-09 1,000 $0.00 1,000 $34.13
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
13,000 2017-10-11 No 4 M Direct
11,000 2018-10-10 No 4 M Direct
8,000 2019-10-09 No 4 M Direct
6,667 2020-10-07 No 4 M Direct
5,667 2021-10-06 No 4 M Direct
Footnotes
  1. Options were granted 10-11-2007 and vested 33% annually over a three year period
  2. Options were granted on 10-10-2008 and vested 33% annually over a three year period
  3. Options were granted on 10-09-2009 and vested 33% annually over a three year period
  4. Options were granted 10-06-2010 and vested 33% annually over a three year period
  5. Options were granted on 10-6-2011 and vested 33% annually over a three year period